<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="chem202501037" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Chemistry</journal-id><journal-id journal-id-type="iso-abbrev">Chemistry</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1521-3765</journal-id><journal-id journal-id-type="publisher-id">CHEM</journal-id><journal-title-group><journal-title>Chemistry (Weinheim an Der Bergstrasse, Germany)</journal-title></journal-title-group><issn pub-type="ppub">0947-6539</issn><issn pub-type="epub">1521-3765</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40202903</article-id><article-id pub-id-type="pmc">PMC12099186</article-id>
<article-id pub-id-type="doi">10.1002/chem.202501037</article-id><article-id pub-id-type="publisher-id">CHEM202501037</article-id><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>In Vitro Psilocybin Synthesis by Co&#x02010;Immobilized Enzymes</article-title></title-group><contrib-group><contrib id="chem202501037-cr-0001" contrib-type="author"><name><surname>Sch&#x000e4;fer</surname><given-names>Tim</given-names></name><xref rid="chem202501037-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="chem202501037-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="chem202501037-cr-0002" contrib-type="author"><name><surname>Sherwood</surname><given-names>Alexander</given-names></name><xref rid="chem202501037-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="chem202501037-cr-0003" contrib-type="author"><name><surname>Kirkland</surname><given-names>Thomas</given-names></name><xref rid="chem202501037-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="chem202501037-cr-0004" contrib-type="author"><name><surname>Kr&#x000fc;ger</surname><given-names>Thomas</given-names></name><xref rid="chem202501037-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="chem202501037-cr-0005" contrib-type="author"><name><surname>Worbs</surname><given-names>Jakob</given-names></name><xref rid="chem202501037-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="chem202501037-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="chem202501037-cr-0006" contrib-type="author"><name><surname>Kniemeyer</surname><given-names>Olaf</given-names></name><xref rid="chem202501037-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="chem202501037-cr-0007" contrib-type="author"><name><surname>Gressler</surname><given-names>Markus</given-names></name><xref rid="chem202501037-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="chem202501037-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="chem202501037-cr-0008" contrib-type="author" corresp="yes"><name><surname>Hoffmeister</surname><given-names>Dirk</given-names></name><xref rid="chem202501037-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="chem202501037-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>dirk.hoffmeister@leibniz-hki.de</email></address></contrib></contrib-group><aff id="chem202501037-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Pharmaceutical Microbiology</named-content>
<institution>Friedrich Schiller University</institution>
<named-content content-type="street">Beutenbergstrasse 11a</named-content>
<city>Jena</city>
<country country="DE">Germany</country>
</aff><aff id="chem202501037-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Pharmaceutical Microbiology</named-content>
<institution>Leibniz Institute for Natural Product Research and Infection Biology &#x02013; Hans Kn&#x000f6;ll Institute</institution>
<named-content content-type="street">Beutenbergstrasse 11a</named-content>
<city>Jena</city>
<country country="DE">Germany</country>
</aff><aff id="chem202501037-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>The Usona Institute</institution>
<named-content content-type="street">2780 Woods Hollow Road</named-content>
<city>Madison</city>
<named-content content-type="country-part">WI</named-content>
<country country="US">USA</country>
</aff><aff id="chem202501037-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Research &#x00026; Development</named-content>
<institution>Promega Corporation</institution>
<named-content content-type="street">2800 Woods Hollow Road</named-content>
<city>Madison</city>
<named-content content-type="country-part">WI</named-content>
<country country="US">USA</country>
</aff><aff id="chem202501037-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Molecular and Applied Microbiology</named-content>
<institution>Leibniz Institute for Natural Product Research and Infection Biology &#x02013; Hans Kn&#x000f6;ll Institute</institution>
<named-content content-type="street">Beutenbergstrasse 11a</named-content>
<city>Jena</city>
<country country="DE">Germany</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>E&#x02010;mail: <email>dirk.hoffmeister@leibniz-hki.de</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="ppub"><day>22</day><month>5</month><year>2025</year></pub-date><volume>31</volume><issue seq="340">29</issue><issue-id pub-id-type="doi">10.1002/chem.v31.29</issue-id><elocation-id>e202501037</elocation-id><history>
<date date-type="received"><day>14</day><month>3</month><year>2025</year></date>
<date date-type="accepted"><day>08</day><month>4</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 Wiley&#x02010;VCH GmbH--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). Chemistry &#x02013; A European Journal published by Wiley&#x02010;VCH GmbH</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:CHEM-31-e202501037.pdf"/><abstract><title>Abstract</title><p>Advanced clinical trials investigate the <italic toggle="yes">Psilocybe</italic> magic mushroom natural product psilocybin as a treatment against major depressive disorder. Currently, synthetic material is used to meet the demand for legitimate pharmaceutical purposes. Here, we report an in vitro approach to biocatalytically produce psilocybin on a solid&#x02010;phase matrix charged with five covalently bound biosynthetic enzymes. These enzymes include three <italic toggle="yes">Psilocybe</italic> enzymes: IasA*, an engineered <sc>l</sc>&#x02010;tryptophan decarboxylase/aromatic aldehyde synthase, the 4&#x02010;hydroxytryptamine kinase PsiK and the norbaeocystin methyltransferase PsiM, along with <italic toggle="yes">Escherichia coli</italic> nucleosidase MtnN and adenine deaminase Ade. In a proof&#x02010;of&#x02010;principle experiment, this enzyme&#x02010;charged resin allowed for quantitative turnover of 4&#x02010;hydroxy&#x02010;<sc>l</sc>&#x02010;tryptophan into psilocybin. This facile process i) represents a sustainable approach with reusable enzymes, ii) circumvents the drawbacks of in vivo processes while harnessing the selectivity of enzymatic catalysis and iii) helps access an urgently needed drug candidate.</p></abstract><abstract id="chem202501037-abs-0001" abstract-type="graphical"><p>The drug candidate and psychedelic mushroom product psilocybin was produced by multienzyme&#x02010;charged beads in a biocatalytic cell&#x02010;free approach. Using immobilized fungal indolethylamine biosynthetic and additional bacterial enzymes, these beads turned over 4&#x02010;hydroxy&#x02010;<sc>l</sc>&#x02010;tryptophan to psilocybin. This approach circumvents the drawbacks of in vivo processes while harnessing the selectivity of enzymatic catalysis
<boxed-text position="anchor" content-type="graphic"><graphic xlink:href="CHEM-31-e202501037-g003.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="chem202501037-kwd-0001">biotechnology</kwd><kwd id="chem202501037-kwd-0002">enzyme</kwd><kwd id="chem202501037-kwd-0003">immobilization</kwd><kwd id="chem202501037-kwd-0004">natural products</kwd><kwd id="chem202501037-kwd-0005">psilocybin</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Deutsche Forschungsgemeinschaft
</institution><institution-id institution-id-type="doi">10.13039/501100001659</institution-id></institution-wrap></funding-source><award-id>TRR 124</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Usona Institute
</institution><institution-id institution-id-type="doi">10.13039/100017478</institution-id></institution-wrap></funding-source></award-group></funding-group><counts><fig-count count="5"/><table-count count="0"/><page-count count="7"/><word-count count="5060"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 22, 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:23.05.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="chem202501037-sec-0010"><label>1</label><title>Introduction</title><p>Psilocybin (Figure&#x000a0;<xref rid="chem202501037-fig-0001" ref-type="fig">1</xref>) is the main natural product of <italic toggle="yes">Psilocybe</italic> mushrooms which cause powerful psychotropic effects when ingested.<sup>[</sup>
<xref rid="chem202501037-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>]</sup> This 4&#x02010;<italic toggle="yes">O</italic>&#x02010;phosphorylated tryptamine is the precursor to the actual psychoactive compound, psilocin (Figure&#x000a0;<xref rid="chem202501037-fig-0001" ref-type="fig">1</xref>), which acts as a partial agonist on various serotonin (5&#x02010;hydroxytryptamine, 5&#x02010;HT) receptors, primarily the cortical 5&#x02010;HT<sub>2A</sub> receptor.<sup>[</sup>
<xref rid="chem202501037-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>]</sup> After having been banned for decades, psilocybin is seeing renewed interest as a candidate medication. Outcomes of Phase 2 clinical trials demonstrate high efficacy in the treatment of major depressive disorder and treatment&#x02010;resistant depression. The United States Food and Drug Administration therefore granted &#x0201c;Breakthrough Therapy&#x0201d; status to psilocybin.<sup>[</sup>
<xref rid="chem202501037-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>]</sup> Other clinical trials focus on cancer&#x02010;related existential distress and substance dependencies as indications.<sup>[</sup>
<xref rid="chem202501037-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>]</sup>
</p><fig position="float" fig-type="Figure" id="chem202501037-fig-0001"><label>Figure 1</label><caption><p>Chemical structures of <italic toggle="yes">Psilocybe</italic> tryptamine natural products.</p></caption><graphic xlink:href="CHEM-31-e202501037-g004" position="anchor" id="jats-graphic-3"/></fig><p>The demand for psilocybin to support legitimate experimental and pharmaceutical purposes has been met by total chemical synthesis. Various protocols exist, including a recently published scalable cGMP&#x02010;compliant procedure.<sup>[</sup>
<xref rid="chem202501037-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>]</sup> However, chemical synthesis may be limited by the complexity of the process and the generation of hazardous waste, making it less sustainable for large&#x02010;scale production. Furthermore, the chemical phosphorylation of psilocin to psilocybin in particular has been shown to be tedious, depending on several narrow critical process parameters to be achieved reproducibly at scale.<sup>[</sup>
<xref rid="chem202501037-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>]</sup>
</p><p>The four enzymes catalyzing the biosynthesis in <italic toggle="yes">Psilocybe</italic> mushrooms have been identified, i.e., the <sc>l</sc>&#x02010;tryptophan decarboxylase PsiD, the P<sub>450</sub> monooxygenase PsiH, the kinase PsiK, and the <italic toggle="yes">N</italic>&#x02010;methyltransferase PsiM.<sup>[</sup>
<xref rid="chem202501037-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>]</sup> These findings set the stage for in vitro biocatalytic production of psilocybin. The procedures include the full enzymatic synthesis, using a step&#x02010;economic route beginning from 4&#x02010;hydroxy&#x02010;<sc>l</sc>&#x02010;tryptophan or from 4&#x02010;hydroxyindole and <sc>l</sc>&#x02010;serine.<sup>[</sup>
<xref rid="chem202501037-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="chem202501037-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>]</sup> as well as the PsiK&#x02010;mediated biocatalytic phosphorylation of synthetic psilocin.<sup>[</sup>
<xref rid="chem202501037-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>]</sup> Alternatively, in vivo approaches with recombinant psilocybin&#x02010;producing microorganisms harboring the biosynthesis genes<sup>[</sup>
<xref rid="chem202501037-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="chem202501037-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>
<sup>]</sup> were reported. The first heterologous production was shown in <italic toggle="yes">Aspergillus nidulans</italic>,<sup>[</sup>
<xref rid="chem202501037-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>
<sup>]</sup> later reproduced with yeast and <italic toggle="yes">E. coli</italic> as hosts and extended to make non&#x02010;natural analogs.<sup>[</sup>
<xref rid="chem202501037-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>
<sup>]</sup> Compared with cellular production in recombinant organisms, in vitro procedures offer i) endotoxin&#x02010; and pyrogen&#x02010;free production conditions, which is preferred from a regulatory standpoint and for application in humans, as well as ii) high product specificity, as only a defined set of enzymes is present.</p><p>To perform a biocatalytic multi&#x02010;step synthesis, an efficient method is to use immobilized enzymes in a flow reactor.<sup>[</sup>
<xref rid="chem202501037-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>
<sup>]</sup> When immobilizing enzymes on solid support for this purpose, preserving the activity of the enzymes is a key consideration. One method for preserving the activity is to fuse the enzyme to a HaloTag protein, a small protein that covalently binds to a specific chloroalkane ligand, which can then be site&#x02010;selectively immobilized on a solid support bearing the cognate chloroalkane (available as beads or resin).<sup>[</sup>
<xref rid="chem202501037-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>
<sup>]</sup> As a proof of concept and to establish a foundation forcontinuously operated flow reactors, we report cell&#x02010;free psilocybin production using enzymes from various sources, covalently immobilized on a functionalized matrix.</p></sec><sec id="chem202501037-sec-0020"><label>2</label><title>Results and Discussion</title><sec id="chem202501037-sec-0030"><label>2.1</label><title>Individual Activity Assays with HaloTag Fusion Proteins</title><p>We aimed at reconstituting psilocybin biosynthesis (Scheme&#x000a0;<xref rid="chem202501037-fig-0004" ref-type="fig">1</xref>) from 4&#x02010;hydroxy&#x02010;<sc>l</sc>&#x02010;tryptophan using PsiD, PsiK and PsiM, thereby circumventing the step catalyzed by the notoriously insoluble PsiH monooxygenase and eliminating the need to add a cytochrome reductase to the system.<sup>[</sup>
<xref rid="chem202501037-bib-0006" ref-type="bibr">
<sup>6a</sup>
</xref>
<sup>]</sup> The enzymes were heterologously produced in <italic toggle="yes">E. coli</italic> KRX and fused to the HaloTag, analogous to similar previously reported applications of this technology.<sup>[</sup>
<xref rid="chem202501037-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>
<sup>]</sup> Unlike chelation with cations, this method covalently attaches enzymes to the matrix, preventing the leaching of heavy metals. In addition, the enzyme&#x02010;charged beads can be magnetically collected to facilitate product purification.</p><fig position="float" fig-type="Scheme" id="chem202501037-fig-0004"><label>Scheme 1</label><caption><p>Cellular and biotechnological assembly of psilocybin. A) Biosynthetic sequence to psilocybin, intrinsic to <italic toggle="yes">Psilocybe</italic> mushrooms. B) Biocatalysis by co&#x02010;immobilized enzymes. PsiD, PsiK, PsiM designate <italic toggle="yes">P. cubensis</italic>
<sc>l</sc>&#x02010;tryptophan decarboxylase, tryptamine&#x02010;4&#x02010;monooxygenase, 4&#x02010;hydroxytryptamine kinase, and norbaeocystin <italic toggle="yes">N</italic>&#x02010;methyltransferase, respectively. IasA*: <italic toggle="yes">P. mexicana</italic> aromatic amino acid decarboxylase/aromatic aldehyde synthase, engineered to replace residue Phe329 by tyrosine; MtnN and Ade: <italic toggle="yes">Escherichia coli S</italic>&#x02010;adenosyl&#x02010;<sc>l</sc>&#x02010;homocysteine nucleosidase and adenine deaminase, respectively, the grey sphere represents the HaloTag bead.</p></caption><graphic xlink:href="CHEM-31-e202501037-g005" position="anchor" id="jats-graphic-5"/></fig><p>In our work, the tagged and matrix&#x02010;bound enzymes were first tested individually to verify they had retained their catalytic activity. Both the pyridoxal&#x02010;5&#x02010;phosphate (PLP)&#x02010;independent gateway decarboxylase PsiD and the kinase PsiK showed (near&#x02010;)quantitative conversion (Figure&#x000a0;<xref rid="chem202501037-fig-0002" ref-type="fig">2</xref>) of the substrates added at a final concentration of 50&#x000a0;&#x000b5;<sc>m</sc>. To prevent PsiM inhibition by its second product <italic toggle="yes">S</italic>&#x02010;adenosyl&#x02010;<sc>l</sc>&#x02010;homocysteine (SAH), the methyltransferase assays were performed in the presence of N&#x02010;terminally HaloTagged <italic toggle="yes">E. coli</italic> SAH nucleosidase (MtnN) and adenine deaminase (Ade) that together irreversibly remove SAH from the reaction. Like with PsiD and PsiK, the HaloTag did not impact PsiM activity and sequential methylation of the primary amine norbaeocystin into the tertiary amine psilocybin was observed, while the intermediate secondary <italic toggle="yes">N</italic>&#x02010;methylamine baeocystin was only observed in trace amounts (Figure&#x000a0;<xref rid="chem202501037-fig-0002" ref-type="fig">2</xref>). As control, heat&#x02010;inactivated enzymes were used in parallel reactions. For additional control, the fusion enzymes were proteolytically cleaved by HaloTEV protease to elute them from the matrix. Subsequent SDS&#x02010;polyacrylamide gel electrophoresis indicated strong bands at the sizes expected for PsiK and PsiM, while PsiD recovery from the matrix resulted only in a faint band indicating non&#x02010;optimal covalent attachment to the matrix (Figure <xref rid="chem202501037-supinfo-0001" ref-type="">S1</xref>). This suggests that PsiD may not be as effectively immobilized as PsiK and PsiM, potentially affecting its stability and activity in the biocatalytic process.</p><fig position="float" fig-type="Figure" id="chem202501037-fig-0002"><label>Figure 2</label><caption><p>LC&#x02010;MS analysis of in vitro assays to determine the activity of individual halotagged immobilized biosynthesis enzymes (&#x0201c;cycle 1&#x02033;) and their stability after eight consecutive reactions (&#x0201c;cycle 8&#x02033;). Top traces show overlaid chromatograms of standards, bottom traces show negative controls with heat&#x02010;inactivated enzyme. Chromatograms were extracted from UV/Vis spectra at <italic toggle="yes">&#x003bb;</italic> = 280&#x000a0;nm. Mass spectra were extracted from product peaks (indicated by asterisks) after the eighth cycle (except for PsiD). A): Decarboxylation of 4&#x02010;hydroxy&#x02010;<sc>l</sc>&#x02010;tryptophan by PsiD; B) psilocin phosphorylation by PsiK; C) decarboxylation of 4&#x02010;hydroxy&#x02010;<sc>l</sc>&#x02010;tryptophan by IasA* (replacing PsiD); D) N&#x02010;methylation of norbaeocystin to baeocystin and on to psilocybin by PsiM in the presence of <italic toggle="yes">S</italic>&#x02010;adenosyl&#x02010;<sc>l</sc>&#x02010;homocysteine nucleosidase (MtnN) and adenine deaminase (Ade).</p></caption><graphic xlink:href="CHEM-31-e202501037-g002" position="anchor" id="jats-graphic-7"/></fig></sec><sec id="chem202501037-sec-0040"><label>2.2</label><title>Repeated use of Immobilized Enzymes</title><p>For the envisioned solid&#x02010;phase approach to produce psilocybin, the matrix&#x02010;bound enzymes PsiD, PsiK, and PsiM were tested individually for their ability to be reused. They were recovered from an assay, collected after the reaction, and reused, leading to eight consecutive reactions, each freshly set up. PsiM&#x02010;catalyzed reactions were again run in the presence of MtnN and Ade. After eight completed reaction cycles, both PsiK and PsiM catalysts still showed full activity (Figure&#x000a0;<xref rid="chem202501037-fig-0002" ref-type="fig">2</xref>).</p><p>Remarkably, solid phase&#x02010;bound PsiK turned out a highly reusable catalyst as it showed still quantitative turnover from psilocin to psilocybin even after as many as twenty reaction cycles (Figure <xref rid="chem202501037-supinfo-0001" ref-type="">S2</xref>). However, PsiD's activity had faded. Although the first cycle led to a 96% conversion, this value dropped to 26% after the fifth and &#x0003c;&#x000a0;2% after the eighth cycle. This finding suggests that it may have been compromised by immobilization in a way that PsiK and PsiM are not. PsiD is evolutionarily and mechanistically related to phosphatidylserine decarboxylases which autocatalytically remove their C&#x02010;terminal portion, the &#x003b1;&#x02010;subunit, which then serves as cofactor that binds the substrate.<sup>[</sup>
<xref rid="chem202501037-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="chem202501037-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>
<sup>]</sup> As PsiD carries the tag at its N&#x02010;terminus, repeated recovery from the reactions may have insufficiently carried over the &#x003b1;&#x02010;subunit which may have caused the loss of its activity.</p><p>To address this apparent deficiency, we replaced PsiD by IasA from <italic toggle="yes">P. mexicana</italic>, an experimentally verified aromatic aldehyde synthase.<sup>[</sup>
<xref rid="chem202501037-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>
<sup>]</sup> These PLP&#x02010;dependent enzymes share a near&#x02010;indistinguishable evolutionary relationship with aromatic amino acid decarboxylases as a single amino acid residue determines the actual catalytic activity.<sup>[</sup>
<xref rid="chem202501037-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>
<sup>]</sup> We introduced a point mutation to replace this key residue, Phe329, by tyrosine. This engineered enzyme, hereafter referred to as IasA*, was produced in <italic toggle="yes">E. coli</italic> as a C&#x02010;terminal HaloTag fusion, immobilized on the Magne HaloTag Beads resin, and assayed for activity. It showed decarboxylase activity with 4&#x02010;OH&#x02010;<sc>l</sc>&#x02010;tryptophan (Figure&#x000a0;<xref rid="chem202501037-fig-0002" ref-type="fig">2</xref>). The immobilized version was also tested for repeated use and showed full activity after eight reactions (Figure&#x000a0;<xref rid="chem202501037-fig-0002" ref-type="fig">2</xref>).</p></sec><sec id="chem202501037-sec-0050"><label>2.3</label><title>Production of Psilocybin with Co&#x02010;Immobilized Enzymes</title><p>Continuing with the IasA*/PsiK/PsiM combination of biosynthetic enzymes, expanded by MtnN and Ade to remove the co&#x02010;product SAH, we evaluated the feasibility of an in vitro reaction to produce psilocybin, catalyzed by a single multi&#x02010;enzyme matrix all present in a single reaction. We assessed whether the loading of the beads with the tagged enzymes is reproducible. In a triplicate experiment, the covalently bound proteins from independent loading events were released by TEV protease and subjected to tryptic protein digestion. Subsequently, nano LC&#x02010;MS/MS was used to analyze the relative amounts of the released enzymes. The molar ratio of the enzymes PsiK, PsiM, IasA*, MtnN, and Ade was 37:20:11:13:19 (Figure <xref rid="chem202501037-supinfo-0001" ref-type="">S3</xref>). The highest batch&#x02010;to&#x02010;batch variability was &#x000b1;&#x000a0;0.35%. In addition, an absolute photometric protein quantification was performed which indicated 19.6 (&#x000b1; 1.24) &#x000b5;g total protein per mg dried magnetic beads.</p><p>The pathway was reconstituted beginning with 4&#x02010;hydroxy&#x02010;<sc>l</sc>&#x02010;tryptophan (50&#x000a0;&#x000b5;<sc>m</sc>) as substrate, which was readily accepted by IasA*, to eliminate the 4&#x02010;hydroxylation step catalyzed by the poorly soluble monooxygenase PsiH. Consequently, this approach makes a cytochrome P<sub>450</sub> reductase as additional enzyme unnecessary. In the presence of the cofactors PLP, ATP, and SAM, psilocybin was observed as virtually exclusive indolethylamine product in Cycle 1 after 8&#x000a0;h (Figure&#x000a0;<xref rid="chem202501037-fig-0003" ref-type="fig">3</xref>), and constant yields across eight loading cycles (Figure <xref rid="chem202501037-supinfo-0001" ref-type="">S4</xref>). This finding underscores the cooperation between the participating <italic toggle="yes">Psilocybe</italic> and <italic toggle="yes">E. coli</italic> enzymes under homogeneous reaction conditions.</p><fig position="float" fig-type="Figure" id="chem202501037-fig-0003"><label>Figure 3</label><caption><p>LC&#x02010;MS analysis of psilocybin production in vitro using immobilized enzymes. Chromatograms were extracted from UV/Vis spectra at <italic toggle="yes">&#x003bb;</italic> = 280&#x000a0;nm. Upper trace: authentic standards of psilocybin, psilocin, 4&#x02010;hydroxy&#x02010;<sc>l</sc>&#x02010;tryptophan, and 4&#x02010;hydroxytryptamine (overlaid separate chromatograms); center trace: reaction with resin, charged with IasA*, PsiK, PsiM, MtnN, and Ade, and 4&#x02010;hydroxy&#x02010;<sc>l</sc>&#x02010;tryptophan as substrate; bottom trace: negative control with heat&#x02010;inactivated enzymes. + = injection peaks also containing excess ATP as substrate, hypoxanthine as final product, and other compounds. Right panels show the UV&#x02010;Vis and mass spectrum of the produced psilocybin.</p></caption><graphic xlink:href="CHEM-31-e202501037-g001" position="anchor" id="jats-graphic-9"/></fig><p>This study focused on the concerted use of immobilized biosynthesis enzymes to implement a fully biocatalytic, yet easy to handle process to synthesize psilocybin, a promising future medication against major depressive disorder. The multi&#x02010;enzyme in vitro biocatalysis represents a versatile method that avoids toxic waste and the use of heavy metals in chemical syntheses as well as potential and difficult&#x02010;to&#x02010;remove contaminants endotoxins or pyrogens carried over from a microbial host after an in vivo synthesis. Charging the beads is facilitated by highly selective covalent interaction to the target proteins directly in the crude lysate of the heterologous host.</p><p>Prior chromatography is not required which excludes carryover of Ni<sup>2+</sup> or Co<sup>2+</sup> from metal affinity chromatography columns while allowing for intensive wash steps that warrant a contaminant&#x02010;free reaction environment. Furthermore, the enzymes can be magnetically removed after the reaction which facilitates subsequent purification of the product. While the kinetics of PsiK, PsiM, MtnN, and Ade are known,<sup>[</sup>
<xref rid="chem202501037-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="chem202501037-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="chem202501037-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>
<sup>]</sup> future work needs to determine the values for IasA and IasA*. Our current results rely on a single species of charged beads, carrying multiple enzymes. However, the method can be varied by combining single&#x02010;enzyme beads which allows to compensate for kinetically slower, rate&#x02010;limiting steps.</p><p>Our method is not restricted to psilocybin, but offers the modularity and flexibility to easily swap or add enzymes. Future work will include TrpB, the substrate&#x02010;flexible <italic toggle="yes">Psilocybe</italic> tryptophan synthase to use <sc>l</sc>&#x02010;serine and substituted indoles as low&#x02010;cost starting material, e.g., to produce 4&#x02010;hydroxy&#x02010;<sc>l</sc>&#x02010;tryptophan in situ or to generate 6&#x02010;methylpsilocybin or isonorbaeocystin.<sup>[</sup>
<xref rid="chem202501037-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="chem202501037-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>
<sup>]</sup> To supply SAM at a reasonable cost to our process, we also aim at integrating SAM production from ATP and <sc>l</sc>&#x02010;methionine by adding the <italic toggle="yes">Psilocybe cubensis</italic> SAM synthase SamS<sup>[</sup>
<xref rid="chem202501037-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>
<sup>]</sup> or <italic toggle="yes">Escherichia coli</italic> EcMAT.<sup>[</sup>
<xref rid="chem202501037-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>]</sup> Similarly, the method is also applicable for only a single immobilized enzyme. Thus, tedious chemical syntheses are circumvented while integrating the simplicity of tryptamine chemistry,<sup>[</sup>
<xref rid="chem202501037-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>],</sup> e.g., in case of 5&#x02010;methylpsilocybin and other synthetic non&#x02010;natural analogs.<sup>[</sup>
<xref rid="chem202501037-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>]</sup> In particular, the extraordinary stability of PsiK that allowed for 20 consecutive reactions, lays the foundation for regioselective large scale 4&#x02010;<italic toggle="yes">O</italic>&#x02010;phosphorylation in continuously operated reactors.</p><p>The successfully completed proof of concept for biocatalytic psilocybin biosynthesis by solid phase&#x02010;supported enzymes lays the foundation for further in&#x02010;depth investigations of enzyme stability, consistency, increased enzyme loading, and purity across batches. These aspects warrant future investigations with a potential GMP&#x02010;compatible production and regulatory approval process in mind.</p></sec></sec><sec id="chem202501037-sec-0060"><label>3</label><title>Conclusion</title><p>Psilocybin has (re&#x02010;)emerged as a promising candidate drug which translates into an increasing demand for drug substance to supply clinical trials. Besides total and chemoenzymatic syntheses in larger quantities <sup>[</sup>
<xref rid="chem202501037-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="chem202501037-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>]</sup> our in vitro approach with immobilized biosynthetic enzymes adds to the cell&#x02010;free production options. Currently, campaigns are underway that aim at approval of psilocybin as a pharmaceutical in the United States and the European Union. We conclude that our results support these efforts by devising a scalable and universally applicable method for facile access to an urgently needed treatment against major depressive disorder.</p></sec><sec id="chem202501037-sec-0070"><label>4</label><title>Experimental Section</title><sec id="chem202501037-sec-0100"><title>Materials and general procedures</title><p>Chemicals, solvents, and media components were purchased from AstaTech, Roth, Sigma&#x02010;Aldrich, VWR. Authentic standards of baeocystin and norbaeocystin were synthesized as described.<sup>[</sup>
<xref rid="chem202501037-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>
<sup>]</sup> Plasmid isolation, DNA restriction, and ligation followed the instructions of the manufacturers of kits and enzymes (Macherey&#x02010;Nagel, Promega).</p></sec><sec id="chem202501037-sec-0110"><title>Construction of plasmids</title><p>Plasmid pFN19K (Promega) served as vector for expression plasmids. The genes were inserted individually between the <italic toggle="yes">Asi</italic>SI and <italic toggle="yes">Pme</italic>I sites. To introduce these restriction sites, <italic toggle="yes">psiD</italic>, <italic toggle="yes">psiK</italic>, and <italic toggle="yes">psiM</italic> were amplified by PCR from plasmids pJF24, pJF23, and pFB13, respectively.<sup>[</sup>
<xref rid="chem202501037-bib-0006" ref-type="bibr">
<sup>6a</sup>
</xref>
<sup>]</sup> Plasmids pFB15 and pFB16 served to amplify genes for SAH nucleosidase (<italic toggle="yes">mtnN</italic>) and adenine deaminase (<italic toggle="yes">ade</italic>).<sup>[</sup>
<xref rid="chem202501037-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="chem202501037-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>
<sup>]</sup> Ligation of the genes to pFN19K yielded expression plasmids pTS01 (<italic toggle="yes">psiD</italic>), pTS06 (<italic toggle="yes">psiK</italic>), pTS07 (<italic toggle="yes">psiM</italic>), pTS17 (<italic toggle="yes">mtnN</italic>), and pTS18 (<italic toggle="yes">ade</italic>) to produce N&#x02010;terminally halotagged proteins. To produce IasA* as a C&#x02010;terminally halotagged protein carrying a TEV recognition sequence at the fusion site, the <italic toggle="yes">iasA</italic> gene was PCR&#x02010;amplified from pPS66<sup>[</sup>
<xref rid="chem202501037-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>
<sup>]</sup> as two overlapping fragments to replace the phenylalanine by a tyrosine codon. The halotag gene was amplified from pFN19K and the four fragments were assembled by Gibson assembly, yielding plasmid pTS106. For PCR, 200&#x02005;&#x000b5;<sc>m</sc> each dNTP, 10&#x02005;ng template DNA, and 1&#x02005;U <italic toggle="yes">Pfu</italic> DNA polymerase (Promega) in the buffer supplied with the enzyme, were used. Details on PCR conditions and oligonucleotides are provided in Tables <xref rid="chem202501037-supinfo-0001" ref-type="">S1</xref> and <xref rid="chem202501037-supinfo-0001" ref-type="">S2</xref>. Following the PCRs, all products were purified by agarose gel electrophoresis and subsequent elution of the DNA with Promega's Wizard SV Gel and PCR Clean&#x02010;Up System. Expression plasmids pTS17 (<italic toggle="yes">mtnN</italic>) and pTS18 (<italic toggle="yes">ade</italic>) were created by joining the PCR product with pFN19K (co&#x02010;restricted by <italic toggle="yes">Asi</italic>SI and <italic toggle="yes">Pme</italic>I) using the NEBuilder kit (NEB), other expression plasmids were assembled by ligation (T4 DNA ligase, Promega) of <italic toggle="yes">Asi</italic>SI and <italic toggle="yes">Pme</italic>I&#x02010;generated sticky&#x02010;ends.</p></sec><sec id="chem202501037-sec-0120"><title>Heterologous production and immobilization of PsiD, PsiM, PsiK, IasA*, MtnN, and Ade</title><p>To produce halotagged enzymes, <italic toggle="yes">E. coli</italic> KRX (Promega) was individually transformed with plasmids pTS01, pTS06, pTS07, pTS17, pTS18, and pTS106. The main cultures (1&#x000a0;L each) in LB medium, supplemented with 50&#x000a0;&#x000b5;g&#x000a0;mL<sup>&#x02212;1</sup> kanamycin, were inoculated with a 5&#x000a0;mL overnight seed culture at 37&#x000b0;C and 180&#x000a0;rpm and induced with 0.1% <sc>l</sc>&#x02010;rhamnose after reaching an OD<sub>600</sub> of 0.6. Subsequently, the temperature was lowered to 16&#x000b0;C, and the flasks were shaken for another 20&#x000a0;h before cell harvest by centrifugation. The biomass was resuspended in lysis buffer (7&#x000a0;mL per 1&#x000a0;L culture volume) containing 50&#x000a0;m<sc>m</sc> TRIS pH 8 and 150&#x000a0;m<sc>m</sc> NaCl. The cells were sonicated on ice, and the debris was removed by centrifugation for 20&#x000a0;min at 13,750&#x000a0;&#x000d7;&#x000a0;g. To immobilize the fusion enzymes on the matrix (Magne HaloTag Beads, Promega), 20&#x000a0;&#x000b5;L of settled magnetic beads (from 100&#x000a0;&#x000b5;L slurry) were mixed with 800&#x000a0;&#x000b5;L cell lysate when a single enzyme was loaded (400&#x000a0;&#x000b5;L lysate per enzyme to simultaneously co&#x02010;charge the matrix with multiple enzymes) and shaken for 30&#x000a0;min. After discarding the flow through, the procedure was repeated for another 30&#x000a0;min. The immobilized enzymes were washed 10 times with 1&#x000a0;mL of the respective reaction buffer (Section 4.4) before substrate and cofactors (if applicable) were added. For control, aliquots of the loaded matrix were removed to release bound enzyme using the HaloTEV protease (Promega) for subsequent analysis by SDS&#x02010;polyacrylamide gel electrophoresis (Figure <xref rid="chem202501037-supinfo-0001" ref-type="">S1</xref>).</p></sec><sec id="chem202501037-sec-0130"><title>In vitro assays with single immobilized enzymes</title><p>Triplicate reactions were set up in 50&#x000a0;m<sc>m</sc> phosphate buffer (pH 6.6 for PsiD and pH 7.0 for PsiK), or 50&#x000a0;m<sc>m</sc> TRIS&#x02010;HCl pH 8.0 (reactions with PsiM/MtnN/Ade or IasA*) to meet the pH optima of the individual enzymes. Indolethylamine substrates were added at 50&#x000a0;&#x000b5;<sc>m</sc> (PsiD: 4&#x02010;hydroxy&#x02010;<sc>l</sc>&#x02010;tryptophan, PsiK: psilocin, PsiM: norbaeocystin, IasA*: 4&#x02010;hydroxy&#x02010;<sc>l</sc>&#x02010;tryptophan)<sc>.</sc> For PsiK assays, 100&#x000a0;&#x000b5;<sc>m</sc> ATP and 250&#x000a0;&#x000b5;<sc>m</sc> MgCl<sub>2</sub> were used. For the methyltransferase assay, 300&#x000a0;&#x000b5;<sc>m</sc> SAM and <italic toggle="yes">E. coli</italic> MtnN and Ade, co&#x02010;immobilized with PsiM on the same beads, were added. IasA* assays were run in the presence of 5&#x000a0;&#x000b5;<sc>m</sc> PLP. Reactions were incubated with agitation for 30&#x000a0;min (PsiM for 8&#x000a0;h) at room temperature. Subsequently, the enzyme&#x02010;charged beads were trapped magnetically, before the supernatant was frozen in liquid nitrogen and lyophilized. Assay conditions for repeated enzyme use were as described above. Following an incubation cycle, the enzymes were trapped magnetically, the supernatant was removed and analyzed chromatographically, the enzyme&#x02010;charged beads were washed three times with reaction buffer prior to adding them to a new assay. Eight reactions were run with these enzymes, an additional set of PsiK assays included 20 consecutive reactions.</p></sec><sec id="chem202501037-sec-0140"><title>In vitro assays with combined immobilized enzymes</title><p>The multi&#x02010;enzyme reactions (1&#x000a0;mL total volume) were run in triplicate and included IasA*, PsiK, PsiM, MtnN, and Ade. The proteins were produced individually, the lysates were combined and used to charge the Magne HaloTag Beads as described above. The reactions were set up in 50&#x000a0;m<sc>m</sc> TRIS&#x02010;HCl buffer (pH 8) and 100&#x000a0;&#x000b5;<sc>m</sc> ATP, 250&#x000a0;&#x000b5;<sc>m</sc> MgCl<sub>2</sub>, 300&#x000a0;&#x000b5;<sc>m</sc> SAM, 5&#x000a0;&#x000b5;<sc>m</sc> PLP, and 50&#x000a0;&#x000b5;<sc>m</sc> 4&#x02010;hydroxy&#x02010;<sc>l</sc>&#x02010;tryptophan. Settled beads (20&#x000a0;&#x000b5;L), charged with the respective enzymes, were added to the reactions. They proceeded for 8&#x000a0;h, shaken at 200&#x000a0;rpm, at room temperature. Subsequently, the enzyme&#x02010;charged beads were trapped magnetically and the liquid was frozen in liquid nitrogen, lyophilized, and subsequently dissolved in 100&#x000a0;&#x000b5;L methanol, centrifuged, and used for chromatography (below). After washing the beads three times with buffer, new buffer, substrate, cosubstrate, and cofactors were added to the beads as described above for single&#x02010;enzyme assays. Heat&#x02010;inactivated bead&#x02010;bound enzymes were negative controls.</p></sec><sec id="chem202501037-sec-0150"><title>Protein quantification and analysis</title><p>The immobilized proteins were removed at room temperature for 2&#x000a0;h with 5 U &#x000b5;L<sup>&#x02212;1</sup> HaloTEV protease (Promega) in 500&#x000a0;&#x000b5;L 100&#x000a0;m<sc>m</sc> ammonia bicarbonate buffer, shaking the reaction at 200&#x000a0;rpm. For an in&#x02010;solution digest, proteins were solubilized in 100&#x000a0;&#x000b5;L 100&#x000a0;m<sc>m</sc> ammonium bicarbonate and mixed with 100&#x000a0;&#x000b5;L 2,2,2&#x02010;trifluoroethanol. Cysteine thiols were reduced and carbamidomethylated in one step for 30&#x000a0;min at 70&#x000b0;C by addition of each 4&#x000a0;&#x000b5;L of 500&#x000a0;m<sc>m</sc> tris(2&#x02010;carboxyethyl)phosphine and 625&#x000a0;m<sc>m</sc> 2&#x02010;chloroacetamide per 200&#x000a0;&#x000b5;L sample. Subsequently, sample solutions were evaporated to approximately 100&#x000a0;&#x000b5;L. Proteins were precipitated with methanol (MeOH)/chloroform/H<sub>2</sub>O, following a published procedure<sup>[</sup>
<xref rid="chem202501037-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>
<sup>]</sup> and resolubilized in 100&#x000a0;m<sc>m</sc> tetraethylammonium bicarbonate in 5:95 trifluoroethanol/H<sub>2</sub>O (v/v). Proteins were digested for 18&#x000a0;h at 37&#x000b0;C after addition of Trypsin/Lys&#x02010;C mix at a protease&#x02010;to&#x02010;protein ratio of 1:25. Tryptic peptides were dried in a vacuum concentrator and resolubilized in 30&#x000a0;&#x000b5;L of 0.05% trifluoroacetic acid in H<sub>2</sub>O:acetonitrile (ACN) 98:2 (v/v), filtered through membrane spin filters (10&#x000a0;kDa cut off). The filtrate was transferred to HPLC vials and injected into the chromatograph (below). Each sample was measured in triplicate (three analytical replicates). Photometric protein quantification was performed using the Pierce BCA Protein Assay Kit (Thermo).</p></sec><sec id="chem202501037-sec-0160"><title>Liquid chromatography and mass spectrometry</title><p>To analyze products of single&#x02010;enzyme assays with halotagged PsiD or IasA*, an Agilent 1290 Infinity II UHPLC&#x02010;MS instrument was used, equipped with a diode array detector (DAD) and interfaced to a 6130 quadrupole mass detector, run in positive mode and using an ESI source. The chromatograph was fitted with a Supelco Ascentis Express F5 column (100&#x000a0;&#x000d7;&#x000a0;2.1&#x000a0;mm, 2.7&#x000a0;&#x000b5;m particle size) and a guard column. Separation was at 50&#x000b0;C (flow: 0.5&#x000a0;mL min<sup>&#x02212;1</sup>). Solvent A was 0.1% aqueous formic acid (FA), solvent B was MeOH. A linear gradient was applied (% B): initially 10%, within 8&#x000a0;min to 100%. For PsiK assays, the same chromatograph was fitted with a Phenomenex Luna Omega Polar C18 column (50&#x000a0;&#x000d7;&#x000a0;2.1&#x000a0;mm, 1.6&#x000a0;&#x000b5;m particle size) and an appropriate guard column. Separation was at 25&#x000b0;C and a flow of 0.5&#x000a0;mL min<sup>&#x02212;1</sup>. Solvent A was 0.1% aqueous FA, solvent B was ACN. A linear gradient was applied (%B): initially 1%, within 3&#x000a0;min to 5%, and within further 1&#x000a0;min to 100%. To analyze PsiM/MtnN/Ade assays and psilocybin producing multi&#x02010;enzyme assays, a Supelco Ascentis Express F5 column was used (100&#x000a0;&#x000d7;&#x000a0;2.1&#x000a0;mm, 2.7&#x000a0;&#x000b5;m particle size), thermostatted at 35&#x000b0;C. Solvent A was 0.1% aqueous FA, solvent B was MeOH. A linear gradient at a flow of 0.6&#x000a0;mL min<sup>&#x02212;1</sup> was applied (%B): 0&#x02013;4&#x000a0;min 2%, within further 10&#x000a0;min to 100%.</p><p>Proteins were analyzed on a Thermo Fisher Scientific Ultimate 3000 nano RSLC chromatograph connected to a Q&#x02010;Exactive HF mass spectrometer. Peptide trapping for 5&#x000a0;min on an Acclaim Pep Map 100 column (2&#x000a0;cm&#x000a0;&#x000d7;&#x000a0;75&#x000a0;&#x000b5;m, 3&#x000a0;&#x000b5;m) at 5&#x000a0;&#x000b5;L min<sup>&#x02212;1</sup> was followed by separation on an &#x000b5;PAC neo 110 column. Eluent A was 0.1% aqueous FA, eluent B was 0.1% (v/v) FA in 90:10 ACN:H<sub>2</sub>O. Gradient elution was performed using the following gradient: 0&#x000a0;min at 4% B and 750 nL min<sup>&#x02212;1</sup>, 10&#x000a0;min at 6.5% B and 750 nL min<sup>&#x02212;1</sup>, 12&#x000a0;min at 7% B and 300 nL min<sup>&#x02212;1</sup>, 85&#x000a0;min at 25% B and 300 nL min<sup>&#x02212;1</sup>, 130&#x000a0;min at 50% B and 300 nL min<sup>&#x02212;1</sup>, 135&#x000a0;min at 96% B and 300 nL min<sup>&#x02212;1</sup>, 138&#x02013;140&#x000a0;min at 96% B and 750 nL min<sup>&#x02212;1</sup>, 140.1&#x02013;150&#x000a0;min at 4% B and 750 nL min<sup>&#x02212;1</sup>. Positively charged ions were generated at spray voltage of 2.2&#x000a0;kV using a stainless steel emitter attached to the Nanospray Flex Ion Source. The quadrupole/orbitrap instrument was operated in data&#x02010;dependent acquisition mode. The top 15 most abundant precursor ions per scan cycle underwent HCD fragmentation. Precursor ions were monitored at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 300&#x02013;1500 at a resolution of 120,000 FWHM (full width at half maximum) using a maximum injection time (IT<sub>max</sub>) of 120&#x000a0;ms and an automatic gain control target of 3&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup>. Precursor ions with a charge state of <italic toggle="yes">z</italic>&#x000a0;=&#x000a0;2&#x02013;5 were filtered at an isolation width of <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 4.0 amu for further fragmentation at 30% HCD collision energy. MS<sup>2</sup> ions were scanned at 15,000 FWHM (IT<sub>max</sub>&#x000a0;=&#x000a0;80&#x000a0;ms, AGC&#x000a0;=&#x000a0;2&#x000a0;&#x000d7;&#x000a0;10<sup>5</sup>). Dynamic exclusion was&#x000a0;30&#x000a0;s.</p></sec><sec id="chem202501037-sec-0170"><title>Protein database search</title><p>Tandem mass spectra were searched against the UniProt databases (retrieved on August 19, 2024) of <italic toggle="yes">E. coli</italic> K12, supplemented by the protein sequences of halotagged Ade, IasA*, MtnN, PsiK, and PsiM, using Proteome Discoverer (PD) 3.1 (Thermo) and the database search algorithms (threshold search engine scores in parenthesis) Mascot 2.8 (&#x0003e;30), Comet (&#x0003e;3), MS Amanda 3.0 (&#x0003e;300), Chimerys (&#x0003e;2), Sequest HT (&#x0003e;3) with and without INFERYS Rescoring with Precursor Detector node. Two missed cleavages were allowed for the tryptic digestion. The precursor mass tolerance was set to 10&#x000a0;ppm and the fragment mass tolerance to 0.02&#x000a0;Da. Modifications were defined as dynamic methionine oxidation, phosphorylation of serine, threonine, and tyrosine, protein N&#x02010;terminal acetylation with and without loss of methionine as well as static cysteine carbamidomethylation. A strict false discovery rate &#x0003c;&#x000a0;1% (peptide and protein level) was required for positive protein hits. The Percolator node of PD 3.1 and a reverse decoy database was used for <italic toggle="yes">q</italic>&#x02010;value validation of spectral matches. Only Rank 1 proteins and peptides of the top scored proteins were counted. Label&#x02010;free protein quantification was based on the Minora algorithm of PD 3.1 using the precursor abundance based on intensity and a signal&#x02010;to&#x02010;noise ratio&#x000a0;&#x0003e;&#x000a0;5. The relative percentage distribution of Ade, MtnN, lasA*, PsiM, and PsiK was calculated based on the abundance counts (spectral counting) per protein divided by the respective length of the protein sequence (number of amino acids). The sum of these relative spectral counts of the five proteins was defined as 100%, and the percentage was determined for the individual values. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE <sup>[</sup>
<xref rid="chem202501037-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>]</sup> partner repository with the dataset identifier PXD061303.</p></sec></sec><sec sec-type="COI-statement" id="chem202501037-sec-0190"><title>Conflict of Interests</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="chem202501037-supinfo-0001" position="float" content-type="local-data"/><supplementary-material id="chem202501037-supitem-0001" position="float" content-type="local-data"><caption><p>Supporting information</p></caption><media xlink:href="CHEM-31-e202501037-s001.pdf"/></supplementary-material></sec></body><back><ack id="chem202501037-sec-0180"><title>Acknowledgments</title><p>We are grateful to Professor Dr. Florian P. Seebeck (University of Basel) for providing <italic toggle="yes">E. coli mtnN</italic> and <italic toggle="yes">ade</italic> genes, and to Professor Dr. Jennifer Andexer (University of Freiburg) for valuable advice on chemical analytics. We gratefully acknowledge Dr. Claudius Lenz (Friedrich&#x02010;Schiller&#x02010;Universit&#x000e4;t Jena) for providing 4&#x02010;hydroxytryptamine. This work was supported by the Usona Institute (Madison, WI). Work in D.H.s laboratory is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) &#x02013; Collaborative Research Center SFB 1127 ChemBioSys, project ID 239748522. O.K. and T.K. are supported by the DFG within the Collaborative Research Center/Transregio 124 &#x0201c;FungiNet&#x0201d; (project Z2; project ID 210879364).</p><p>Open access funding enabled and organized by Projekt DEAL.</p></ack><ref-list id="chem202501037-bibl-0001"><ref id="chem202501037-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="chem202501037-cite-0001">
<string-name>
<given-names>F.</given-names>
<surname>Tyls</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Palenicek</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Horacek</surname>
</string-name>, <source>Eur. Neuropsychopharmcol.</source>
<year>2014</year>, <volume>24</volume>, <fpage>342</fpage>.</mixed-citation></ref><ref id="chem202501037-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="chem202501037-cite-0002">
<string-name>
<given-names>F.</given-names>
<surname>Hasler</surname>
</string-name>, <string-name>
<given-names>U.</given-names>
<surname>Grimberg</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Benz</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Huber</surname>
</string-name>, <string-name>
<given-names>F. X.</given-names>
<surname>Vollenweider</surname>
</string-name>, <source>Psychopharmacology</source>
<year>2004</year>, <volume>172</volume>, <fpage>145</fpage>.<pub-id pub-id-type="pmid">14615876</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="chem202501037-cite-0003">a) <string-name>
<given-names>R. B.</given-names>
<surname>Kargbo</surname>
</string-name>, <source>ACS Med. Chem. Lett.</source>
<year>2020</year>, <volume>11</volume>, <fpage>399</fpage>;<pub-id pub-id-type="pmid">32292538</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="chem202501037-cite-0004">b) <string-name>
<given-names>C.</given-names>
<surname>Lenz</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sherwood</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Kargbo</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Hoffmeister</surname>
</string-name>, <source>ChemPlusChem</source>
<year>2021</year>, <volume>86</volume>, <fpage>28</fpage>.<pub-id pub-id-type="pmid">33237633</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="chem202501037-cite-0005">
<string-name>
<given-names>D. E.</given-names>
<surname>Nichols</surname>
</string-name>, <source>J. Antibiot.</source>
<year>2020</year>, <volume>73</volume>, <fpage>679</fpage>.</mixed-citation></ref><ref id="chem202501037-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="chem202501037-cite-0006">a) <string-name>
<given-names>J.</given-names>
<surname>Fricke</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Lenz</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Wick</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Blei</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Hoffmeister</surname>
</string-name>, <source>Chem. &#x02010; Eur. J.</source>
<year>2019</year>, <volume>25</volume>, <fpage>897</fpage>;<pub-id pub-id-type="pmid">30011099</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="chem202501037-cite-0007">b) <string-name>
<given-names>R. B.</given-names>
<surname>Kargbo</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sherwood</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Walker</surname>
</string-name>, <string-name>
<given-names>N. V.</given-names>
<surname>Cozzi</surname>
</string-name>, <string-name>
<given-names>R. E.</given-names>
<surname>Dagger</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Sable</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>O'Hern</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Kaylo</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Patterson</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Tarpley</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Meisenheimer</surname>
</string-name>, <source>ACS Omega</source>
<year>2020</year>, <volume>5</volume>, <elocation-id>16959</elocation-id>.<pub-id pub-id-type="pmid">32685866</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="chem202501037-cite-0008">a) <string-name>
<given-names>J.</given-names>
<surname>Fricke</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Blei</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Hoffmeister</surname>
</string-name>, <source>Angew. Chem. Intl. Ed.</source>
<year>2017</year>, <volume>56</volume>, <elocation-id>12352</elocation-id>;</mixed-citation><mixed-citation publication-type="journal" id="chem202501037-cite-0009">b) <string-name>
<given-names>T.</given-names>
<surname>Sch&#x000e4;fer</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Kramer</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Werten</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Rupp</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Hoffmeister</surname>
</string-name>, <source>ChemBioChem</source>
<year>2022</year>, <volume>23</volume>, <elocation-id>e202200551</elocation-id>.<pub-id pub-id-type="pmid">36327140</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="chem202501037-cite-0010">
<string-name>
<given-names>F.</given-names>
<surname>Blei</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Baldeweg</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Fricke</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Hoffmeister</surname>
</string-name>, <source>Chem. &#x02010; Eur. J.</source>
<year>2018</year>, <volume>24</volume>, <elocation-id>10028</elocation-id>.<pub-id pub-id-type="pmid">29750381</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="chem202501037-cite-0011">
<string-name>
<given-names>J.</given-names>
<surname>Fricke</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Kargbo</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Regestein</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Lenz</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Peschel</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Rosenbaum</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sherwood</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Hoffmeister</surname>
</string-name>, <source>Chem. &#x02010; Eur. J.</source>
<year>2020</year>, <volume>26</volume>, <fpage>8281</fpage>.<pub-id pub-id-type="pmid">32101345</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="chem202501037-cite-0012">
<string-name>
<given-names>H. T.</given-names>
<surname>Reynolds</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Vijayakumar</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Gluck&#x02010;Thaler</surname>
</string-name>, <string-name>
<given-names>H. B.</given-names>
<surname>Korotkin</surname>
</string-name>, <string-name>
<given-names>P. B.</given-names>
<surname>Matheny</surname>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>Slot</surname>
</string-name>, <source>Evol. Lett.</source>
<year>2018</year>, <volume>2</volume>, <fpage>88</fpage>.<pub-id pub-id-type="pmid">30283667</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="chem202501037-cite-0013">a) <string-name>
<given-names>S.</given-names>
<surname>Hoefgen</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Lin</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Fricke</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Stroe</surname>
</string-name>, <string-name>
<given-names>D. J.</given-names>
<surname>Mattern</surname>
</string-name>, <string-name>
<given-names>J. E.</given-names>
<surname>Kufs</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Hortschansky</surname>
</string-name>, <string-name>
<given-names>A. A.</given-names>
<surname>Brakhage</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Hoffmeister</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Valiante</surname>
</string-name>, <source>Metab. Eng.</source>
<year>2018</year>, <volume>48</volume>, <fpage>44</fpage>;<pub-id pub-id-type="pmid">29842926</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="chem202501037-cite-0014">b) <string-name>
<given-names>S.</given-names>
<surname>Janevska</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Weiser</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Huang</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Lin</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Hoefgen</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Barber</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Sch&#x000e4;fer</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Fricke</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Hoffmeister</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Regestein</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Valiante</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Kufs</surname>
</string-name>, <source>Microb. Biotechnol.</source>
<year>2024</year>, <volume>17</volume>, <elocation-id>e70039</elocation-id>.<pub-id pub-id-type="pmid">39487767</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="chem202501037-cite-0015">a) <string-name>
<given-names>A. M.</given-names>
<surname>Adams</surname>
</string-name>, <string-name>
<given-names>N. A.</given-names>
<surname>Kaplan</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Wei</surname>
</string-name>, <string-name>
<given-names>J. D.</given-names>
<surname>Brinton</surname>
</string-name>, <string-name>
<given-names>C. S.</given-names>
<surname>Monnier</surname>
</string-name>, <string-name>
<given-names>A. L.</given-names>
<surname>Enacopol</surname>
</string-name>, <string-name>
<given-names>T. A.</given-names>
<surname>Ramelot</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Jones</surname>
</string-name>, <source>Metab. Eng.</source>
<year>2019</year>, <volume>56</volume>, <fpage>111</fpage>;<pub-id pub-id-type="pmid">31550507</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="chem202501037-cite-0016">b) <string-name>
<given-names>N.</given-names>
<surname>Milne</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Thomsen</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>M&#x000f8;lgaard Knudsen</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Rubaszka</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kristensen</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Borodina</surname>
</string-name>, <source>Metab. Eng.</source>
<year>2020</year>, <volume>60</volume>, <fpage>25</fpage>;<pub-id pub-id-type="pmid">32224264</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="chem202501037-cite-0017">c) <string-name>
<given-names>J. E.</given-names>
<surname>Flower</surname>
</string-name>, <string-name>
<given-names>W. J.</given-names>
<surname>Gibbons Jr</surname>
</string-name>, <string-name>
<given-names>A. M.</given-names>
<surname>Adams</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>C. N.</given-names>
<surname>Broude</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Jones</surname>
</string-name>, <source>Biotechnol. Bioeng.</source>
<year>2023</year>, <volume>120</volume>, <fpage>2214</fpage>.<pub-id pub-id-type="pmid">37337917</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="chem202501037-cite-0018">a) <string-name>
<given-names>Y.&#x02010;J.</given-names>
<surname>Hu</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>Y.&#x02010;Q.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Zhu</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Fang</surname>
</string-name>, <string-name>
<given-names>J.&#x02010;H.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Guo</surname>
</string-name>, <source>Chem. Eng. J.</source>
<year>2022</year>, <volume>437</volume>, <elocation-id>135400</elocation-id>;</mixed-citation><mixed-citation publication-type="journal" id="chem202501037-cite-0019">b) <string-name>
<given-names>K.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Zheng</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Zheng</surname>
</string-name>, <source>Front. Bioeng. Biotechnol.</source>
<year>2020</year>, <volume>8</volume>, <fpage>660</fpage>.<pub-id pub-id-type="pmid">32695758</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="chem202501037-cite-0020">
<string-name>
<given-names>H.</given-names>
<surname>Motejadded</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Kranz</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Berensmeier</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Franzreb</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Altenbuchner</surname>
</string-name>, <source>Appl. Biochem. Biotechnol.</source>
<year>2010</year>, <volume>162</volume>, <fpage>2098</fpage>.<pub-id pub-id-type="pmid">20473582</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="chem202501037-cite-0021">a) <string-name>
<given-names>J.</given-names>
<surname>D&#x000f6;bber</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Pohl</surname>
</string-name>, <source>J. Biotechnol.</source>
<year>2017</year>, <volume>241</volume>, <fpage>170</fpage>;<pub-id pub-id-type="pmid">27923737</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="chem202501037-cite-0022">b) <string-name>
<given-names>J.</given-names>
<surname>D&#x000f6;bber</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Gerlach</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Offermann</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Rother</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Pohl</surname>
</string-name>, <source>Green Chem.</source>
<year>2018</year>, <volume>20</volume>, <fpage>544</fpage>.</mixed-citation></ref><ref id="chem202501037-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="chem202501037-cite-0023">
<string-name>
<given-names>I.</given-names>
<surname>Schuiki</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Daum</surname>
</string-name>, <source>IUBMB Life</source>
<year>2009</year>, <volume>61</volume>, <fpage>151</fpage>.<pub-id pub-id-type="pmid">19165886</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="chem202501037-cite-0024">
<string-name>
<given-names>P. S.</given-names>
<surname>Seibold</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>D&#x000f6;rner</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Fricke</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Sch&#x000e4;fer</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Beemelmanns</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Hoffmeister</surname>
</string-name>, <source>Fungal Biol. Biotechnol.</source>
<year>2024</year>, <volume>11</volume>, <fpage>4</fpage>.<pub-id pub-id-type="pmid">38664850</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="chem202501037-cite-0025">a) <string-name>
<given-names>M. P.</given-names>
<surname>Torrens&#x02010;Spence</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Ding</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Harich</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Gillaspy</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Li</surname>
</string-name>, <source>J. Biol. Chem.</source>
<year>2013</year>, <volume>288</volume>, <fpage>2376</fpage>;<pub-id pub-id-type="pmid">23204519</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="chem202501037-cite-0026">b) <string-name>
<given-names>M. P.</given-names>
<surname>Torrens&#x02010;Spence</surname>
</string-name>, <string-name>
<given-names>Y. C.</given-names>
<surname>Chiang</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Smith</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Vicent</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>J. K.</given-names>
<surname>Wenig</surname>
</string-name>, <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2020</year>, <volume>117</volume>, <elocation-id>10806</elocation-id>.<pub-id pub-id-type="pmid">32371491</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="chem202501037-cite-0027">
<string-name>
<given-names>J.</given-names>
<surname>Hudspeth</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Rogge</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>D&#x000f6;rner</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>M&#x000fc;ll</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Hoffmeister</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Rupp</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Werten</surname>
</string-name>, <source>Nat. Commun.</source>
<year>2024</year>, <volume>15</volume>, <fpage>2709</fpage>.<pub-id pub-id-type="pmid">38548735</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="chem202501037-cite-0028">a) <string-name>
<given-names>F.</given-names>
<surname>Della Ragione</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Porcelli</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Carten&#x000ec;&#x02010;Farina</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Zappia</surname>
</string-name>, <string-name>
<given-names>A. E.</given-names>
<surname>Pegg</surname>
</string-name>, <source>Biochem. J.</source>
<year>1985</year>, <volume>232</volume>, <fpage>335</fpage>;<pub-id pub-id-type="pmid">3911944</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="chem202501037-cite-0029">b) <string-name>
<given-names>H.</given-names>
<surname>Matsui</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Shimaoka</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Kawasaki</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Takenaka</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Kurahashi</surname>
</string-name>, <source>Biosci. Biotechnol. Biochem.</source>
<year>2001</year>, <volume>65</volume>, <fpage>1112</fpage>.<pub-id pub-id-type="pmid">11440125</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="chem202501037-cite-0030">a) <string-name>
<given-names>J.</given-names>
<surname>Fricke</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sherwood</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Kargbo</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Orry</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Blei</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Naschberger</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Rupp</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Hoffmeister</surname>
</string-name>, <source>ChemBioChem</source>
<year>2019</year>, <volume>20</volume>, <fpage>2824</fpage>.<pub-id pub-id-type="pmid">31150155</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="chem202501037-cite-0031">
<string-name>
<given-names>R.</given-names>
<surname>Demmler</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Fricke</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>D&#x000f6;rner</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Gressler</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Hoffmeister</surname>
</string-name>, <source>ChemBioChem</source>
<year>2020</year>, <volume>21</volume>, <fpage>1364</fpage>.<pub-id pub-id-type="pmid">31802575</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="chem202501037-cite-0032">
<string-name>
<given-names>S.</given-names>
<surname>Mordhorst</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Siegrist</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>M&#x000fc;ller</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Richter</surname>
</string-name>, <string-name>
<given-names>J. N.</given-names>
<surname>Andexer</surname>
</string-name>, <source>Angew. Chem. Intl. Ed.</source>
<year>2017</year>, <volume>56</volume>, <fpage>4037</fpage>.</mixed-citation></ref><ref id="chem202501037-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="chem202501037-cite-0033">
<string-name>
<given-names>M. E.</given-names>
<surname>Speeter</surname>
</string-name>, <string-name>
<given-names>W. C.</given-names>
<surname>Anthony</surname>
</string-name>, <source>J. Am. Chem. Soc.</source>
<year>1954</year>, <volume>76</volume>, <fpage>6208</fpage>.</mixed-citation></ref><ref id="chem202501037-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="chem202501037-cite-0034">
<string-name>
<given-names>J.</given-names>
<surname>Fricke</surname>
</string-name>, <string-name>
<given-names>A. M.</given-names>
<surname>Sherwood</surname>
</string-name>, <string-name>
<given-names>A. L.</given-names>
<surname>Halberstadt</surname>
</string-name>, <string-name>
<given-names>R. B.</given-names>
<surname>Kargbo</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Hoffmeister</surname>
</string-name>, <source>J. Nat. Prod.</source>
<year>2021</year>, <volume>84</volume>, <fpage>1403</fpage>.<pub-id pub-id-type="pmid">33667102</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="chem202501037-cite-0035">
<string-name>
<given-names>A. M.</given-names>
<surname>Sherwood</surname>
</string-name>, <string-name>
<given-names>A. L.</given-names>
<surname>Halberstadt</surname>
</string-name>, <string-name>
<given-names>A. K.</given-names>
<surname>Klein</surname>
</string-name>, <string-name>
<given-names>J. D.</given-names>
<surname>McCorvy</surname>
</string-name>, <string-name>
<given-names>K. W.</given-names>
<surname>Kaylo</surname>
</string-name>, <string-name>
<given-names>R. B.</given-names>
<surname>Kargbo</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Meisenheimer</surname>
</string-name>, <source>J. Nat. Prod.</source>
<year>2020</year>, <volume>83</volume>, <fpage>461</fpage>.<pub-id pub-id-type="pmid">32077284</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="chem202501037-cite-0036">a) <string-name>
<given-names>A.</given-names>
<surname>Vit</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Misson</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Blankenfeldt</surname>
</string-name>, <string-name>
<given-names>F. P.</given-names>
<surname>Seebeck</surname>
</string-name>, <source>ChemBioChem</source>
<year>2015</year>, <volume>16</volume>, <fpage>119</fpage>;<pub-id pub-id-type="pmid">25404173</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="chem202501037-cite-0037">b) <string-name>
<given-names>L.</given-names>
<surname>Misson</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Burn</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Vit</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Hildesheim</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Beliaeva</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Blankenfeldt</surname>
</string-name>, <string-name>
<given-names>F. P.</given-names>
<surname>Seebeck</surname>
</string-name>, <source>ACS Chem. Biol.</source>
<year>2018</year>, <volume>13</volume>, <fpage>1333</fpage>.<pub-id pub-id-type="pmid">29658702</pub-id>
</mixed-citation></ref><ref id="chem202501037-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="chem202501037-cite-0038">
<string-name>
<given-names>D.</given-names>
<surname>Wessel</surname>
</string-name>, <string-name>
<given-names>U. I.</given-names>
<surname>Fl&#x000fc;gge</surname>
</string-name>, <source>Anal. Biochem.</source>
<year>1984</year>, <volume>138</volume>, <fpage>141</fpage>.<pub-id pub-id-type="pmid">6731838</pub-id>
</mixed-citation></ref></ref-list></back></article>